Vincent Chen

Has grant

Assistant Professor

University of Michigan Medical School

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Predictive models for incident cirrhosis in non-alcoholic fatty liver disease using genetic and electronic medical record-based risk factors

Open Date: 2022-07-01

Close Date: 2027-03-01

Grant: Close

Integrating genetic and environmental factors to predict risk of non-alcoholic fatty liver disease

Open Date: 2020-07-01

Close Date: 2022-06-01

Articles (20)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Fang Li

Assistant Professor

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Elizabeth K Speliotes

University of Michigan

UNITED STATES

View details

Anna SF Lok

University of Michigan

UNITED STATES

View details

Neehar D. Parikh

University of Michigan

UNITED STATES

View details

Kelly Cushing

Clinical Lecturer

University of Michigan

UNITED STATES

View details

Karn Wijarnpreecha

Associate Clinical Professor

University of Arizona College of Medicine

UNITED STATES

View details

Mary Feitosa

Associate Professor

Washington University School of Medicine

UNITED STATES

View details

Albert Vernon Smith

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vincent Chen

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Disparities among ethnic groups in mortality and outcomes among adults with MASLD: A multicenter study.

Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank.

Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease

Editorial: clinical outcomes in lean NAFLD – the devil is in the details. Authors' reply

Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities

Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting.

Knockout of murine Lyplal1 confers sex-specific protection against diet-induced obesity.

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization.

Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis.

PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.

Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases.

Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.

PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.

The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019.

Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease.

A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts.

Editorial: MTTP, hepatic steatosis and plasma lipids - still more questions than answers.

Rising incidence and impact of early-onset colorectal cancer in the Asia-Pacific with higher mortality in females from Southeast Asia: a global burden analysis from 2010 to 2019.

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis.

Collaborators (8)

Fang Li

Elizabeth K Speliotes

Anna SF Lok

Neehar D. Parikh

Kelly Cushing

Karn Wijarnpreecha

Mary Feitosa

Albert Vernon Smith

Make your next move.